GlassScriptPhysician profile
Richard C Baynosa
NPI 1881718021
$44,350.87
in general payments reported to CMS, 2019-2025
39 companies · $7,467 in 2025
The $7,467 reported for 2025 was more than what 95% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,337 · 2020: $2,399 · 2021: $1,184 · 2022: $13K · 2023: $7,406 · 2024: $10K · 2025: $7,467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Consulting Fee: $7,995 · Travel and Lodging: $2,230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,905.21 |
| Consulting Fee | $7,994.50 |
| Travel and Lodging | $2,230.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $7,267.30 | 2021-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $6,871.66 | 2023-2025 | Alloderm, Natrelle Saline-Filled Breast Implants, Revolve |
| Motiva USA, LLC | $6,771.23 | 2024-2025 | |
| Rti Surgical, INC | $6,748.58 | 2021-2025 | |
| Allergan, INC. | $4,787.67 | 2019-2022 | |
| Axogen | $2,429.29 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Davol INC. | $2,321.71 | 2022-2025 | Phasix Mesh, Arista, Arista Ah Flexitip |
| Surgical Innovation Associates, INC. | $1,500.00 | 2022 | |
| Mentor Worldwide LLC | $911.10 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Kls-Martin L.P. | $579.73 | 2019-2024 | |
| Intuitive Surgical, INC. | $489.85 | 2019-2025 | |
| Becton, Dickinson and Company | $357.78 | 2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $295.58 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Kerecis Limited | $283.70 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Smith+Nephew, INC. | $260.61 | 2019-2023 | Pico, Stravix |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $226.71 | 2022-2023 | Irrisept |
| Tepha INC | $194.76 | 2019 | |
| Avita Medical Americas, LLC | $178.76 | 2024 | |
| Sonex Health, INC. | $168.13 | 2023 | Sx-One Microknife |
| Stryker Corporation | $166.21 | 2019-2025 | Molli |
| Sientra, INC. | $163.48 | 2021 | |
| Polynovo North America LLC | $161.11 | 2022-2024 | Novosorb Btm |
| Bard Peripheral Vascular, INC. | $153.42 | 2021 | |
| Foundation Medicine, INC. | $148.30 | 2021 | |
| Goode Surgical INC | $124.84 | 2022 | |
| Osiris Therapeutics INC. | $118.90 | 2019 | |
| Sonavex, INC. | $110.50 | 2019 | |
| Kci USA, INC. | $83.45 | 2022 | |
| Acera Surgical, INC. | $82.60 | 2020-2025 | Restrata Wound Matrix |
| Organogenesis INC. | $81.03 | 2023-2024 | Puraply, Puraply Am |
| Musculoskeletal Transplant Foundation INC. | $66.47 | 2024-2025 | |
| Tactile Systems Technology INC | $64.55 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Urgo Medical North America, LLC | $39.52 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Aroa Biosurgery Incorporated | $35.16 | 2024 | |
| Baxter Healthcare | $29.93 | 2019 | |
| Bioventus LLC | $22.16 | 2022 | |
| Biocircuit Technologies INC | $21.86 | 2024 | |
| Coopersurgical, INC. | $17.07 | 2024 | Fisherbrand Disposable Liquid Infant Heel Warmer |
| Medtronic, INC. | $16.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Baynosa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.